NANOGP8 Human Pre-designed siRNA Set A contains three designed siRNAs for NANOGP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NanoLuc substrate 1 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are […]

NanoLuc substrate 2 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are […]

NANOS1 Human Pre-designed siRNA Set A contains three designed siRNAs for NANOS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NANOS2 Human Pre-designed siRNA Set A contains three designed siRNAs for NANOS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NANOS3 Human Pre-designed siRNA Set A contains three designed siRNAs for NANOS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NANP Human Pre-designed siRNA Set A contains three designed siRNAs for NANP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NANS Human Pre-designed siRNA Set A contains three designed siRNAs for NANS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAP1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAP1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAP1L3 Human Pre-designed siRNA Set A contains three designed siRNAs for NAP1L3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAP1L4 Human Pre-designed siRNA Set A contains three designed siRNAs for NAP1L4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAPA Human Pre-designed siRNA Set A contains three designed siRNAs for NAPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAPB Human Pre-designed siRNA Set A contains three designed siRNAs for NAPB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAPEPLD Human Pre-designed siRNA Set A contains three designed siRNAs for NAPEPLD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAPG Human Pre-designed siRNA Set A contains three designed siRNAs for NAPG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Naphthol AS-BI is a substrate of β-glucuronidase and produces a bright red effect after staining biological tissues.

Naphthol AS-BI N-acetyl-β-D-glucosaminide acts as a substrate and reacts directly with N-acetyl-β-glucosaminidase enzyme. Naphthol AS-BI N-acetyl-β-D-glucosaminide can detect and localize the active region of N-acetyl-β-glucosaminidase enzyme visually[1].

Napropamide (Standard) is the analytical standard of Napropamide. This product is intended for research and analytical applications. Napropamide is an amide herbicide.

Naproxen (Standard) is the analytical standard of Naproxen. This product is intended for research and analytical applications. Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay.

Naproxen glucuronide ((S)-Naproxen-β-D-glucuronide) is a non-selective COX inhibitor. Naproxen glucuronide, a metabolite of naproxen, is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class (the same as ibuprofen) that relieves pain, fever, swelling, and stiffness[1].

Naproxen (sodium) (Standard) is the analytical standard of Naproxen (sodium). This product is intended for research and analytical applications. Naproxen sodium is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay.

NAPRT Human Pre-designed siRNA Set A contains three designed siRNAs for NAPRT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAPSA Human Pre-designed siRNA Set A contains three designed siRNAs for NAPSA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Napyradiomycin B4 is a Napyradiomycin derivative, which inhibits the RANKL-induced MEK-ERK signaling pathway. Napyradiomycin B4 attenuates osteoclastogenesis and prevents alveolar bone destruction in experimental periodontitis[1].

NARF Human Pre-designed siRNA Set A contains three designed siRNAs for NARF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NARS1 Human Pre-designed siRNA Set A contains three designed siRNAs for NARS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NARS2 Human Pre-designed siRNA Set A contains three designed siRNAs for NARS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NASP Human Pre-designed siRNA Set A contains three designed siRNAs for NASP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT10 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT14 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT2 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT8 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT8L Human Pre-designed siRNA Set A contains three designed siRNAs for NAT8L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NAT9 Human Pre-designed siRNA Set A contains three designed siRNAs for NAT9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Natrexone/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Natrexone (HY-76711) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

NAV1 Human Pre-designed siRNA Set A contains three designed siRNAs for NAV1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nav1.7 blocker 1 (example 41) is a Na+ channel (Nav) blocker with an IC50 value of 0.037 μM. Nav1.7 blocker 1 can be used for the study of pain, including neuropathic pain, postoperative pain, inflammatory pain, and so on[1].

Nav1.7-IN-13 (compound 3g) is a sodium channel inhibitor that significantly inhibits Veratridine (HY-N6691)-induced neuronal activity. Nav1.7-IN-13 inhibits total Na+ current in DRG neurons in a concentration-dependent manner; slows down the activation of Navs. Nav1.7-IN-13 significantly alleviated mechanical pain behavior in a rat model of nerve injury (SNI) and had analgesic activity[1].

Nav1.8-IN-10 (Compound 6) is a Nav1.8 channel inhibitor. When the concentration is 4 nM, the percentage blocking rate of Nav1.8 channel is 79.4%. Nav1.8-IN-10 can be used in the study of pain disorders[1].

Nav1.8-IN-11 (Example 1) is a Nav1.8 channel inhibitor with a IC50 value of 0.1 nM. Nav1.8-IN-11 can be used in the study of pain disorders[1].

Nav1.8-IN-12 (Compound 23 R) is a Nav1.8 channel inhibitor. Nav1.8-IN-12 can be used in the study of pain-related diseases[1].